NOV 09, 2017 10:12 PM PST

FDA Acts on Bogus Marijuana-based Cancer Therapeutics

WRITTEN BY: Carmen Leitch

The U.S. Food and Drug Administration (FDA) has issued warnings because of four companies that are marketing unproven marijuana-based products as preventing, treating or even curing cancer. That is an illegal act because the claims are unsubstantiated. The FDA sent letters were sent to Greenroads Health, Natural Alchemist, That's Natural! Marketing and Consulting and Stanley Brothers Social Enterprises LLC. The products being sold online by these companies supposedly contain a chemical found in marijuana, cannabidiol (CBD), which has not been approved by the FDA as a drug product for any condition.

"Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors," said FDA commissioner Dr. Scott Gottlieb. "We don't let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we're not going to look the other way on enforcing these principles when it comes to marijuana-containing products."

"There are a growing number of effective therapies for many cancers. When people are allowed to illegally market agents that deliver no established benefit they may steer patients away from products that have proven, anti-tumor effects that could extend lives."

Many products that contain CBD have entered the market, like teas, oils, syrups, capsules, creams, and lotions. They are being sold as therapeutics that can reverse or halt cancer, or other serious diseases including Alzheimer’s. There is, however, no evidence to back up these sweeping pronouncements that are unfortunately directed at very vulnerable people. 

Not only is the sale and marketing of these items a clear violation of the Federal Food, Drug and Cosmetic Act, it could also be putting people’s health in serious jeopardy. People may be seeking out and using these kinds of drugs instead of obtaining medical care from health professionals, which could seriously hinder a patient’s ability to get well. 

"We recognize that there's interest in developing therapies from marijuana and its components, but the safest way for this to occur is through the drug approval process -- not through unsubstantiated claims made on a website," Gottlieb said.

While marijuana may have tremendous potential as a medicinal product, the FDA wants sellers to prove their claims before peddling these products as therapeutics./Image Credit: Marijuana Wellness Products, Hollywood, Portland, Oregon / Credit: Wikimedia Commons/Another Believer

The FDA has sent over 90 letters in the past ten years to address this issue. The agency noted that over 25 products have been sold as inhibitors of “cell division and growth with certain types of cancer,” which contain a chemical that “combats tumor and cancer cells” because "CBD makes cancer cells commit suicide without killing other cells.”
 
The FDA is not against products that contain chemicals derived from marijuana; they only want to make sure they are safe and effective before being sold to people who need help. "We support sound, scientifically-based research using components derived from marijuana, and we'll continue to work with product developers who are interested in bringing safe, effective, and quality products to market,” Commissioner Gottlieb concluded.

Doctors and patients are encouraged to come forward if they have an adverse reaction, or quality issue with an “FDA-regulated drug, biologic, medical device, dietary supplement or cosmetic.” Their MedWatch program also looks for counterfeit medical devices.

Source: FDA

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 20, 2019
Genetics & Genomics
DEC 20, 2019
Can We Cure Down's Syndrome with Gene Therapy?
Down’s Syndrome (DS) is a genetic disorder brought on by the presence of all of part of a third copy of chromosome 21. Linked to delays in physical g...
DEC 20, 2019
Neuroscience
DEC 20, 2019
Hand-Motion Center of the Brain Involved in Speech
During a long-term study focused on improving computer-assistant interfaces for quadriplegia patients, researchers at Stanford University were able to use...
DEC 26, 2019
Cell & Molecular Biology
DEC 26, 2019
Learning More About How Mosquitoes Gain Resistance to Insecticides
When insecticides are used repeatedly over time to kill mosquitoes, they become less effective as the insects gain resistance to their impacts....
JAN 07, 2020
Immunology
JAN 07, 2020
"Good" T Cells Can Go "Bad," But in the Case of Cancer, That's A Good Thing
T cells may be able to reach their full potential in the fight against cancer with a little nudge. In 2010, scientists first observed CD4+ T cells transiti...
JAN 26, 2020
Cell & Molecular Biology
JAN 26, 2020
Using Stem Cells to Treat Chronic Pain
Scientists have used a mouse model to show that human stem cells could be used to engineer neurons that stop pain....
FEB 13, 2020
Immunology
FEB 13, 2020
Protein that suppresses immune system linked to lupus
  A study published in Human Immunology has described, for the first time, a link between an immunosuppressive protein on the surface of T cells and t...
Loading Comments...